-
公开(公告)号:US20110045028A1
公开(公告)日:2011-02-24
申请号:US12516536
申请日:2007-11-29
IPC分类号: A61K31/513 , A61K9/00 , A61P7/02 , A61P9/10
CPC分类号: A61K31/506 , A61K9/2018 , A61K9/2054
摘要: Disclosed is a sustained-release preparation which is prepared by shaping a granule comprising a blood coagulation factor Xa inhibitor and a mixture of at least two hydrophilic polymers. Also disclosed is a pharmaceutical composition comprising a combination of the sustained-release preparation and an immediate release preparation comprising a blood coagulation factor Xa inhibitor. It becomes possible to provide a controlled release preparation comprising a blood coagulation factor Xa inhibitor for the prevention or treatment of thrombosis, which can control the activity of blood coagulation factor Xa for a long term and is excellent in convenience and compliance. It is also becomes possible to provide a method for producing the controlled release preparation.
摘要翻译: 公开了一种缓释制剂,其通过使包含凝血因子Xa抑制剂和至少两种亲水性聚合物的混合物的颗粒成形而制备。 还公开了包含缓释制剂和包含凝血因子Xa抑制剂的速释制剂的组合的药物组合物。 可以提供一种控制释放制剂,其包含凝血因子Xa抑制剂,用于预防或治疗血栓形成,其可以长期控制凝血因子Xa的活性,并且方便性和顺应性优异。 也可以提供一种制备控释制剂的方法。